CapyFin

Calendar Reports

Search for a symbol...

Loading...

CapyFin Real-time Earnings Reports.

Products

Earnings
API

Get in Touch

Contact Us
X (Twitter)
LinkedIn

Resources

Privacy Policy
Terms of Service
Sign Up
Sign In

© 2026 CapyFin. All rights reserved.

Disclaimer: CapyFin provides financial data and AI analysis for informational purposes only and does not provide investment advice or recommendations. Real-time data and AI outputs may be inaccurate, incomplete, delayed, or contain errors or hallucinations. Investing involves risk, including loss of principal. The service is provided “as is” and we disclaim liability to the fullest extent permitted by law. See our Terms of Service and Privacy Policy.

Monte Rosa Therapeutics - CapyFin

Monte Rosa Therapeutics

GLUE · NASDAQ🇺🇸

Earnings Dividends Seasonality Metrics

Reported earnings 3 months ago

Previous year: $1.06M

Previous year: -$0.53

Research and Development Expenses

Previous year: $27M

General and Administrative Expenses

Previous year: $8.99M

Total Operating Expenses

Previous year: $36M

Loading...

Key Statistics

Market Cap

$1.56B

P/E Ratio

271.20

Sector

N/A

Industry

N/A

52-Week High

$25.3

52-Week Low

$3.69

Research and Development Expenses

$32.2M

General and Administrative Expenses

$8.7M

Total Operating Expenses

$40.9M

Interest Income, Net

$3.44M

Provision for Income Taxes

$822K

Monte Rosa Therapeutics

Monte Rosa Therapeutics

Unlock previous datapoints

Monte Rosa Therapeutics Revenue by Geographic Location

Revenue by Geographic Location

Switzerland Revenue

CapyFin.com

Historical Earnings Impact

Analyze how earnings announcements historically affect stock price performance

Avg. Return Before/After Earnings

Loading earnings performance data...

Loading earnings reaction data...